{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:24:24Z","timestamp":1762352664834},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"without financial"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4288-7","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:53:50Z","timestamp":1522810430000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol"],"prefix":"10.1186","volume":"18","author":[{"given":"Anna Carolina","family":"Miola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane Roio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Patricia Fernandes","family":"Abbade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliano Vilaverde","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"4288_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/carcin\/23.1.181","volume":"23","author":"C Berking","year":"2002","unstructured":"Berking C, Takemoto R, Binder RL, Hartman S, Ruiter TJ, Gallagher PM, Lessin SR, Herlyn M. Photocarcinogenesis in human adult skin grafts. Carcinogenesis. 2002;23:181\u20137.","journal-title":"Carcinogenesis"},{"key":"4288_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1067\/mjd.2000.103342","volume":"42","author":"SJ Salasche","year":"2000","unstructured":"Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"4288_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","volume":"46","author":"R Rossi","year":"2007","unstructured":"Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol. 2007;46:895\u2013904.","journal-title":"Int J Dermatol"},{"key":"4288_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1067\/mjd.2000.103343","volume":"42","author":"RL Moy","year":"2000","unstructured":"Moy RL. Clinical presentation of actinic keratoses an squamous cell carcinoma. J Am Acad Dermatol. 2000;42:8\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"4288_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","volume":"1","author":"R Marks","year":"1988","unstructured":"Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma in the skin: a prospective study. Lancet. 1988;1:795\u20137.","journal-title":"Lancet"},{"key":"4288_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. \u201cField cancerization\u201d in oral stratified squamous epithelium. Cancer (Phila.). 1953;6:963\u20138.","journal-title":"Cancer (Phila.)"},{"key":"4288_CR7","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter\u2019s concept of field cancerization evidence and clinical implications. Cancer Res. 2003;63:1727\u201330.","journal-title":"Cancer Res"},{"key":"4288_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccr.2007.06.012","volume":"12","author":"GD Dakubo","year":"2007","unstructured":"Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int. 2007;12:1\u201312.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"4288_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1590\/abd1806-4841.20132300","volume":"88","author":"LAR Torezan","year":"2013","unstructured":"Torezan LAR, Festa-Neto C. Cutaneous field cancerization: clinical, histopathological and therapeutic aspects. An Bras Dermatol. 2013;88(5):779\u201391.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"4288_CR10","first-page":"241","volume":"89","author":"B Berman","year":"2012","unstructured":"Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Cutis. 2012;89(5):241\u201350.","journal-title":"Cutis"},{"issue":"2","key":"4288_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","volume":"156","author":"D De Berker","year":"2007","unstructured":"De Berker D, McGregor JM, Hughes BR. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156(2):222\u201330.","journal-title":"Br J Dermatol"},{"issue":"3","key":"4288_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1590\/abd1806-4841.20153302","volume":"90","author":"MC Oliveira","year":"2015","unstructured":"Oliveira MC, Pinto CAL, Pinto JCCL, Trevisan F, Xavier CA. Histopatological analysis of the therapeutic response to cryotherapy with liquid nitrogen in patients with multiple actinic keratosis. An Bras Dermatol. 2015;90(3):384\u20139.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"4288_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1590\/S0365-05962011000400003","volume":"86","author":"CS Poziomczyk","year":"2011","unstructured":"Poziomczyk CS, Koche B, Dornelles MA, Dornelles SIT. Pain evaluation in the cryosurgery onf actinic keratosis. An Bras Dermatol. 2011;86(4):645\u201350.","journal-title":"An Bras Dermatol"},{"key":"4288_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1067\/mjd.2002.119649","volume":"47","author":"RM Szeimies","year":"2002","unstructured":"Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am AcadDermatol. 2002;47:258\u201362.","journal-title":"J Am AcadDermatol"},{"key":"4288_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1586\/edm.10.13","volume":"5","author":"E Bagatin","year":"2010","unstructured":"Bagatin E. 5-fluorouracil for actinic keratoses. Exp RevDermatol. 2010;5:131\u20139.","journal-title":"Exp RevDermatol"},{"key":"4288_CR16","first-page":"517","volume":"30","author":"J Labandeira","year":"2004","unstructured":"Labandeira J, Pereiro M, Vald\u00e9s F, Toribio J. Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg. 2004;30:517\u201320.","journal-title":"Dermatol Surg"},{"key":"4288_CR17","unstructured":"Okada C, Guimar\u00e3es Z, Miot HA. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative Study. Dermatol Surg. 2014;40(6):610-7."},{"issue":"6","key":"4288_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jac\/48.6.751","volume":"48","author":"DH Dockrell","year":"2001","unstructured":"Dockrell DH, Kinghorn GR. Imiquimod and resiquimod as novel immunomodulators. J Antimicrob Chemother. 2001;48(6):751\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"4288_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mjd.2002.126257","volume":"47","author":"SJ Salasche","year":"2002","unstructured":"Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial. J Am Acad Dermatol. 2002;47:571\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4288_CR20","first-page":"486","volume":"66","author":"RH Rosen","year":"2012","unstructured":"Rosen RH, Med MM, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Dermatology Elsevier Inc. 2012;66(3):486\u201393.","journal-title":"J Am Dermatology Elsevier Inc"},{"issue":"11","key":"4288_CR21","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","volume":"366","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366(11):1010\u20139.","journal-title":"N Engl J Med"},{"key":"4288_CR22","first-page":"167","volume":"5","author":"B Berman","year":"2006","unstructured":"Berman B, Villa AM, Ramirez CC. Mechanisms of action of new treatment modalities for actinic keratosis. J Drugs Dermatol. 2006;5:167\u201373.","journal-title":"J Drugs Dermatol"},{"key":"4288_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-4362.2001.01324.x","volume":"40","author":"JR Wolf","year":"2001","unstructured":"Wolf JR, Taylor JR, Tschen E. Topical 3% diclofenac in 2,5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709\u201313.","journal-title":"Int J Dermatol"},{"issue":"4","key":"4288_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/abd1806-4841.20131803","volume":"88","author":"M Ianhez","year":"2013","unstructured":"Ianhez M, Fleury LFF Jr, Miot HA, Bagatin E. Retinoids for prevention and treatment ofactinic keratosis. An Bras Dermatol. 2013;88(4):585\u201393.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"4288_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1590\/S0365-05962009000500002","volume":"84","author":"LA Torezan","year":"2009","unstructured":"Torezan LA, Niwa AB, Neto CF. Photodynamic therapy in dermatology: basic principles. An Bras Dermatol. 2009;84(5):445\u201359.","journal-title":"An Bras Dermatol"},{"issue":"7","key":"4288_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/DSS.0000000000000800","volume":"42","author":"DM Ozog","year":"2016","unstructured":"Ozog DM, Rkein AM, Fabi SG, Gold MH, Goldman MP, Lowe NJ, et al. Photodynamic Therapy: A Clinical Consensus Guide. Dermatol Surg. 2016;42(7):804\u201327.","journal-title":"Dermatol Surg"},{"issue":"5","key":"4288_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1590\/S0365-05962009000500002","volume":"84","author":"L Torezan","year":"2009","unstructured":"Torezan L, Niwa ABM, Festa NC. Terapia fotodinamica em dermatologia: principios basicos e aplicacoes. An Bras Dermatol. 2009;84(5):445\u201359.","journal-title":"An Bras Dermatol"},{"key":"4288_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000246376","volume":"192","author":"RM Szeimies","year":"1996","unstructured":"Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 1996;192:246\u201351.","journal-title":"Dermatology"},{"key":"4288_CR29","first-page":"26","volume":"6","author":"CA Morton","year":"2014","unstructured":"Morton CA, Szeimies R-M, Bratheen LR. Update on topical photodynamic therapy for skin cancer. JEADV. 2014;6:26\u201334.","journal-title":"JEADV"},{"key":"4288_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.jid.5700048","volume":"126","author":"E Angell-Petersen","year":"2006","unstructured":"Angell-Petersen E, Sorensen R, Warloe T, Soler AM, Moan J, Peng Q, et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol. 2006;126:265\u201371.","journal-title":"J Invest Dermatol"},{"key":"4288_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1468-3083.2006.01902.x","volume":"21","author":"PG Calzavara-Pinton","year":"2007","unstructured":"Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol. 2007;21:293\u2013302.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4288_CR32","first-page":"349","volume-title":"Lasers in cutaneous and aesthetic surgery","author":"JS Nelson","year":"1997","unstructured":"Nelson JS, McCullough JL, Berns MW. Principles and applications of photodynamic therapy in dermatology. In: Ardnt KA, Dover JS, Olbright SM, editors. Lasers in cutaneous and aesthetic surgery. Philadelphia: Lippincot-Raven; 1997. p. 349\u201382."},{"key":"4288_CR33","first-page":"140","volume":"5","author":"MS Nestor","year":"2006","unstructured":"Nestor MS, Gold MH, Kauvar ANB, Taub AF, Geronemus RG, Ritvo EC, et al. The use of phodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5:140\u201354.","journal-title":"J Drugs Dermatol."},{"key":"4288_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/archderm.1982.01650190007008","volume":"118","author":"FD Malkinson","year":"1982","unstructured":"Malkinson FD. Colchicine: new uses of an old, old drug. Arch Dermatol. 1982;118:453\u20137.","journal-title":"Arch Dermatol"},{"key":"4288_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11926-002-0073-2","volume":"4","author":"Y Molad","year":"2002","unstructured":"Molad Y. Update on colchicine and its mechanism of action. Curr Rheumatol Rep. 2002;4:252\u20136.","journal-title":"Curr Rheumatol Rep"},{"key":"4288_CR36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/j.1875-9114.1991.tb02629.x","volume":"11","author":"M Levy","year":"1991","unstructured":"Levy M, Spino M, Read SE. Colchicine: a state of the art review. Pharmacotherapy. 1991;11:196\u2013211.","journal-title":"Pharmacotherapy"},{"key":"4288_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0190-9622(98)70275-0","volume":"39","author":"TP Sullivan","year":"1998","unstructured":"Sullivan TP, King LE, As B. Colchicine in dermatology. J Am Acad Dermatol. 1998;39:993\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"4288_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2133.1968.tb12345.x","volume":"80","author":"J Marshall","year":"1968","unstructured":"Marshall J. Treatment of solar keratoses with topically applied cytostatic agents. Br J Dermatol. 1968;80:540\u20132.","journal-title":"Br J Dermatol"},{"issue":"4","key":"4288_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/09546630152696314","volume":"12","author":"A Akar","year":"2001","unstructured":"Akar A, B\u00fclent Ta\u015ftan H, Erbil H, Arca E, Kurumlu Z, G\u00fcr AR. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. J Dermatolog Treat. 2001;12(4):199\u2013203.","journal-title":"J Dermatolog Treat"},{"key":"4288_CR40","first-page":"1063","volume":"26","author":"LR Braathen","year":"2012","unstructured":"Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJP, Gilaberte Y, et al. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in dermatology. JEADV. 2012;26:1063\u20136.","journal-title":"JEADV"},{"issue":"9","key":"4288_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00403-013-1413-y","volume":"305","author":"M Ianhez","year":"2013","unstructured":"Ianhez M, Fleury Junior LF, Bagatin E, Miot HA. The reliability of counting actinic keratosis. Arch Dermatol Res. 2013;305(9):841\u20134.","journal-title":"Arch Dermatol Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4288-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:18:56Z","timestamp":1720203536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4288-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"26 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of the institution in 7 dec, 2015 (n. 1.356.401) and consent to participate is attached below.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"340"}}